Multiple antigen-engineered DC vaccines with or without IFNα to promote antitumor immunity in melanoma
Abstract Background Cancer vaccines are designed to promote systemic antitumor immunity and tumor eradication. Cancer vaccination may be more efficacious in combination with additional interventions that may build on or amplify their effects. Methods Based on our previous clinical and in vitro studi...
Main Authors: | Lisa H. Butterfield, Lazar Vujanovic, Patricia M. Santos, Deena M. Maurer, Andrea Gambotto, Joel Lohr, Chunlei Li, Jacob Waldman, Uma Chandran, Yan Lin, Huang Lin, Hussein A. Tawbi, Ahmad A. Tarhini, John M. Kirkwood |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2019-04-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40425-019-0552-x |
Similar Items
-
Identification of subtypes correlated with tumor immunity and immunotherapy in cutaneous melanoma
by: Qian Liu, et al.
Published: (2021-01-01) -
Immune based therapy for melanoma
by: Robert Ancuceanu, et al.
Published: (2016-01-01) -
Current Status and Prospects of Immunotherapy for Gynecologic Melanoma
by: Mayuka Anko, et al.
Published: (2021-05-01) -
The Role of PTEN Loss in Immune Escape, Melanoma Prognosis and Therapy Response
by: Rita Cabrita, et al.
Published: (2020-03-01) -
Improved Anti-Tumour Adaptive Immunity Can Overcome the Melanoma Immunosuppressive Tumour Microenvironment
by: Nana Dang, et al.
Published: (2019-10-01)